1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Pain Therapeutics Market
2.2. Global Pain Therapeutics Market, By Drug, 2023 (US$ Million)
2.3. Global Pain Therapeutics Market, By Pain, 2023 (US$ Million)
2.4. Global Pain Therapeutics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Pain Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Pain Therapeutics Market Vendors
3.2. Strategies Adopted by Pain Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Pain Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pain Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
5.3.2. Opioids
5.3.3. Anesthetics
5.3.4. Anticonvulsants
5.3.5. Corticosteroids
5.3.6. Antidepressants
5.3.7. Other

6. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Nociceptive Pain
6.3.1.1. Somatic Pain
6.3.1.2. Visceral Pain
6.3.1.3. Cutaneous Pain
6.3.2. Neuropathic Pain
6.3.3. Psychogenic Pain


7. North America Pain Therapeutics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
7.3. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
7.4.Pain Therapeutics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
7.4.1.1.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
7.4.1.2.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
7.4.1.3.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)

8. UK and European Union Pain Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.3. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
8.4.Pain Therapeutics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.4.1.1.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.4.1.2.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.4.1.3.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.4.1.4.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.4.1.5.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
8.4.1.6.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)

9. Asia Pacific Pain Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.3. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
9.4.Pain Therapeutics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.4.1.1.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.4.1.2.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.4.1.3.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.4.1.4.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.4.1.5.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
9.4.1.6.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)

10. Latin America Pain Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
10.3. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
10.4.Pain Therapeutics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
10.4.1.1.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
10.4.1.2.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
10.4.1.3.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)

11. Middle East and Africa Pain Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
11.3. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
11.4.Pain Therapeutics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
11.4.1.1.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
11.4.1.2.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Pain Therapeutics Market: By Drug, 2022-2032, USD (Million)
11.4.1.3.2. Pain Therapeutics Market: By Pain, 2022-2032, USD (Million)

12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. AstraZeneca plc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Biogen Idec Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Bristol-Myers Squibb and Company
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Depomed Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Eli Lily and Company
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. GlaxoSmithKline PLC.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Johnson & Johnson Services Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Mallinckrodt plc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Merck & Co. Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Novartis AG
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Pfizer Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Purdue Pharma L.P.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Sanofi S.A.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Other Notable Players
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives